Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAdalan Ventures Regulatory News (ZAIM)

  • This share is currently suspended. It was suspended at a price of 4.50

Share Price Information for Adalan Ventures (ZAIM)

Share Price is delayed by 15 minutes
Get Live Data
4.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £3.48m
ZAIM Live PriceLast checked at - London Stock Exchange

Intraday Adalan Ventures Share Chart

Half-year Financial Report

29 Dec 2025 17:28

RNS Number : 0406N
Adalan Ventures PLC
29 December 2025
 

Not for release or distribution, directly or indirectly, within, into or in the United States or to or for the account or benefit of persons in the United States, Australia, Canada, Japan or any other jurisdiction where such offer or sale would violate the relevant securities laws of such jurisdiction.

 

For Immediate Release

29th December 2025

Adalan Ventures Plc

("Adalan" or the "Company")

Unaudited Interim results for 6 months ended 30 June 2024

 

Adalan Ventures plc (the 'Company' or 'Adalan'), announces its unaudited interim results for the 6 month period ended 30 June 2024.

 

The results follow at the bottom of this announcement.

 

 

Enquiries:

 

Adalan Ventures Plc

Siro Cicconi

 

Tel: +44 (0) 73 9377 9849

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

Adalan Ventures plc

Interim Condensed Consolidated Statement of profit or loss and Other Comprehensive Income for the six months ended 30 June

 

 

Notes

Six months ended 30 June 2024

Unaudited

£

Six months ended 30

June 2023

Unaudited

£

Staff Costs

(114,464)

-

Operating expenses

(93,711)

(10,000)

Loss before income tax

 

(208,175)

(10,000)

 

Income tax expense

-

Net loss

 

(208,175)

(10,000)

 

 

 

 

Net other comprehensive income that may be reclassified to profit or loss

 

 

 

Foreign exchange differences arising on translation into presentation currency

 

-

-

 

Total comprehensive loss

(208,175)

(10,000)

Adalan Ventures plc

Interim Condensed Consolidated Statement of financial position as at

 

 

Notes

30 June

2024

Unaudited

£

31 December 2023

Audited

£

 

Assets:

 

Cash and cash equivalents

 

6,664

58,116

Total Assets

 

6,664

58,116

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

Other liabilities

 

(789,670)

(633,947)

Total liabilities

 

(789,670)

(633,947)

Net Assets

 

(783,006)

(574,831)

 

 

 

Equity

 

 

 

Capital and reserves:

 

 

 

Share capital

8

513,475

513,475

Deferred Share Capital

4,157,775

4,157,775

Share Premium

8

6,910,128

6,910,128

Share options Reserve

 

119,640

119,640

Accumulated deficit

(12,484,024)

(12,275,849)

Total equity

 

(783,006)

(574,831)

Total liabilities and equity

 

6,664

58,116

 

 

Interim Condensed Statement of changes in shareholders' equity (Unaudited) for the six months ended 30 June 2024 (unaudited)

 

 

Share capital

£

 

 

 

Deferred Share Capital

£

Share Premium

£

 

 

 

Share options Reserve

£

 Accumulated 

Deficit

£

 TotalEquity

£

Balance as at 1 January 2024

513,475

 

4,157,775

 

6,910,128

 

119,640

 

(12,275,849)

 

(574,831)

Issue of ordinary shares

-

-

-

-

-

-

Comprehensive loss for the period

-

-

-

-

(208,175)

(208,175)

Share-based payments

-

-

-

-

-

-

Balance as at 30 June 2024

513,475

 

4,157,775

6,910,128

 

119,640

(12,484,024)

(783,006)

 

 

Interim Condensed Consolidated Statement of Cash Flows

For the six months ended 30 June

 

 

 

 

 

Six months ended 30

June 2024

Unaudited

£

Six months

ended 30

June 2023

Unaudited

£

Cash flows from operating activities

 

Loss for the period

(208,175)

(10,000)

Cash from operations

(208,175)

(10,000)

Net (increase)/decrease in operating assets

 

Change in receivables

-

Change in payables

155,723

4,000

Net change in working capital

155,723

4,000

Net cash flows from operating activities

(52,452))

(6,000)

Net change in cash and cash equivalents

(52,452)

(6,000)

 

Cash and cash equivalents at the beginning of the year

58,116

35,468

Effects of Foreign exchange

1,000

-

Cash and cash equivalents at the end of the period

6,664

29,468

 

 

 

2.  Basis of preparation

 

The condensed consolidated interim financial statements have been prepared using accounting policies consistent with International Financial Reporting Standards and in accordance with International Accounting Standard 34 Interim Financial Reporting. The condensed interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2022, which have been prepared in accordance with International Financial Reporting Standards (IFRS).

 

The condensed consolidated interim financial statements set out above do not constitute statutory accounts within the meaning of the Companies Act 2006. They have been prepared on a going concern basis in accordance with the recognition and measurement criteria of International Financial Reporting Standards (IFRS). Statutory financial statements for the year ended 31 December 2023 were approved by the Board of Directors on 11 February 2025 and delivered to the Registrar of Companies. The report of the auditors on those financial statements was unqualified.

 

The condensed consolidated interim financial statements of the Company have not been audited or reviewed by the Company's auditor, RPG Crouch Chapman LLP.

 

Going concern

 

The Financial Statements have been prepared on a going concern basis. The Directors consider that the Company requires additional funding in order to deliver on its plan to find and acquire an operating business and undertake a reverse take over. The Directors are of the view that its current cash reserves along with any funding that it will seek to raise would provide sufficient funds to undertake its operating activities for the foreseeable future. Should the company be unsuccessful in raising additional capital then there is a significant risk that it has the ability to continue as a going concern. The company has currently reduced its cash expenditure to a minimum.

Please refer to the going concern note in the annual report for the year ended 31 December 2023 for further information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR DKLFLELLLFBL
12
Date   Source Headline
15th May 20267:00 amRNSNotice of AGM
30th Apr 20267:00 amRNSAudited Results for FY 2025
30th Mar 20267:00 amRNSIssue of Equity, CLN & Warrants
3rd Mar 20267:00 amRNSDirectorate change
29th Jan 20263:46 pmRNSResult of AGM
6th Jan 202610:13 amRNSNotice of AGM
31st Dec 20257:00 amRNSHalf-year Financial Report
29th Dec 20255:43 pmRNSAnnual Financial Report
29th Dec 20255:28 pmRNSHalf-year Financial Report
22nd Oct 202511:40 amRNSStatement re Reverse Takeover
4th Aug 202512:59 pmRNSResult of General Meeting
17th Jul 20251:00 pmRNSNotice of GM
17th Mar 20254:25 pmRNSFinal Results
7th Dec 20237:00 amRNSStatement re Reverse Takeover
14th Nov 20238:50 amRNSIssue of Equity
25th Oct 202311:24 amRNSResult of AGM
7th Sep 20232:02 pmRNSStatement re Annual Results
1st Sep 20231:28 pmRNSAudited Final Results
28th Jul 202311:04 amRNSStatement re Completion of Share Consolidation
25th Jul 202311:55 amRNSStatement re Share Consolidation
24th Jul 20233:52 pmRNSResult of Meeting
6th Jul 202312:49 pmRNSNotice of GM
2nd May 202312:57 pmRNSStatement re. Temporary Suspension
2nd May 20237:30 amRNSSuspension - Zaim Credit Systems Plc
23rd Mar 202311:58 amRNSResult of Meeting
17th Feb 20237:00 amRNSNotice of GM & New Corporate Website
18th Jan 20231:03 pmRNSUpdate on operations in Russia
18th Jan 20231:00 pmRNSHalf-year Report
28th Sep 20227:57 amRNSStatement re. Suspension
28th Sep 20227:30 amRNSSuspension - Zaim Credit Systems Plc
1st Sep 20227:00 amRNSSecond quarter 2022 trading update
29th Jun 20222:10 pmRNSResult of AGM
22nd Jun 20227:00 amRNSFirst quarter 2022 trading update
26th May 20227:00 amRNSPosting of Annual Report and notice of 2022 AGM
18th May 20227:00 amRNSFinal Results
4th May 20222:05 pmRNSPublication date for 2021 Accounts
14th Mar 20227:30 amRNSFourth quarter and full year 2021 trading update
8th Mar 20227:00 amRNSStatement on current situation in Russia
16th Feb 20222:05 pmRNSSecond Price Monitoring Extn
16th Feb 20222:00 pmRNSPrice Monitoring Extension
23rd Nov 20217:00 amRNSInvestor Presentation Call
15th Nov 20217:00 amRNSThird quarter 2021 trading update
20th Oct 20217:00 amRNSUpdated Corporate Presentation
30th Sep 20217:00 amRNSHalf-year Report
23rd Sep 20217:00 amRNSSecond quarter 2021 trading update
2nd Jul 20217:00 amRNSLaunch of Mobile Application
30th Jun 20216:14 pmRNSTotal Voting Rights
16th Jun 20217:00 amRNSFundraise and Total Voting Rights
7th Jun 202112:31 pmRNSResult of AGM
1st Jun 20217:00 amRNSFirst quarter 2021 trading update
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.